Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14


Pharmacotherapy of emotional and behavioral symptoms associated with autism spectrum disorder in children and adolescents.

Stepanova E, Dowling S, Phelps M, Findling RL.

Dialogues Clin Neurosci. 2017 Dec;19(4):395-402.


Autism spectrum disorder: Consensus guidelines on assessment, treatment and research from the British Association for Psychopharmacology.

Howes OD, Rogdaki M, Findon JL, Wichers RH, Charman T, King BH, Loth E, McAlonan GM, McCracken JT, Parr JR, Povey C, Santosh P, Wallace S, Simonoff E, Murphy DG.

J Psychopharmacol. 2018 Jan;32(1):3-29. doi: 10.1177/0269881117741766. Epub 2017 Dec 14.


Treatment of Autism Spectrum Disorder in Children and Adolescents.

DeFilippis M, Wagner KD.

Psychopharmacol Bull. 2016 Aug 15;46(2):18-41.


The co-occurrence of autism and attention deficit hyperactivity disorder in children - what do we know?

Leitner Y.

Front Hum Neurosci. 2014 Apr 29;8:268. doi: 10.3389/fnhum.2014.00268. eCollection 2014. Review.


What's in the pipeline? Drugs in development for autism spectrum disorder.

Sung M, Chin CH, Lim CG, Liew HS, Lim CS, Kashala E, Weng SJ.

Neuropsychiatr Dis Treat. 2014 Feb 20;10:371-81. doi: 10.2147/NDT.S39516. eCollection 2014. Review.


Effects of extended release methylphenidate treatment on ratings of attention-deficit/hyperactivity disorder (ADHD) and associated behavior in children with autism spectrum disorders and ADHD symptoms.

Pearson DA, Santos CW, Aman MG, Arnold LE, Casat CD, Mansour R, Lane DM, Loveland KA, Bukstein OG, Jerger SW, Factor P, Vanwoerden S, Perez E, Cleveland LA.

J Child Adolesc Psychopharmacol. 2013 Jun;23(5):337-51. doi: 10.1089/cap.2012.0096.


Influence of stimulant-induced hyperactivity on social approach in the BTBR mouse model of autism.

Silverman JL, Babineau BA, Oliver CF, Karras MN, Crawley JN.

Neuropharmacology. 2013 May;68:210-22. doi: 10.1016/j.neuropharm.2012.07.042. Epub 2012 Aug 8.


Treatment for co-occurring attention deficit/hyperactivity disorder and autism spectrum disorder.

Davis NO, Kollins SH.

Neurotherapeutics. 2012 Jul;9(3):518-30. doi: 10.1007/s13311-012-0126-9. Review.


Autism and related disorders.

McPartland J, Volkmar FR.

Handb Clin Neurol. 2012;106:407-18. doi: 10.1016/B978-0-444-52002-9.00023-1. Review.


Self-referenced processing, neurodevelopment and joint attention in autism.

Mundy P, Gwaltney M, Henderson H.

Autism. 2010 Sep;14(5):408-29. doi: 10.1177/1362361310366315. Review.


Central tetrahydrobiopterin concentration in neurodevelopmental disorders.

Frye RE.

Front Neurosci. 2010 Jul 8;4:52. doi: 10.3389/fnins.2010.00052. eCollection 2010.


Tetrahydrobiopterin as a novel therapeutic intervention for autism.

Frye RE, Huffman LC, Elliott GR.

Neurotherapeutics. 2010 Jul;7(3):241-9. doi: 10.1016/j.nurt.2010.05.004. Review.



Levy SE, Mandell DS, Schultz RT.

Lancet. 2009 Nov 7;374(9701):1627-38. doi: 10.1016/S0140-6736(09)61376-3. Epub 2009 Oct 12. Review. Erratum in: Lancet. 2011 Oct 29;378(9802):1546.

Supplemental Content

Support Center